ÂÜÀòÂÒÂ×

Dr. Cohen is Professor of Medicine (Neurology) in the Cleveland Clinic Lerner College of Medicine and Staff Neurologist at the Cleveland Mellen MS Center, where he is Director of Experimental Therapeutics. He has had a leadership role in many clinical trials in the multiple sclerosis field, including having served as Global Principal Investigator for TRANSFORMS (fingolimod), ACT (Avonex), IMPACT (Avonex), GATE (glatiramer acetate), and RADIANCE (ozanimod). Dr. Cohen received his undergraduate degree in Zoology from Connecticut College and his MD from the University of Chicago.